Goldman Sachs Makes Positive Comments on CVS (CVS) Ahead of Results
CVS Hot Sheet
Rating Summary:7 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 25 | Down: 12 | New: 36
Goldman Sachs issued positive comments today on CVS Caremark Corporation (NYSE: CVS) ahead of earnings due on Nov 5, reiterating their Conviction Buy List rating and $40 price target.
The firm sees EPS of $0.64, in-line with the consensus and at the high-end of co guidance; the firm sees the 2009 guidance range of $2.59-$2.64 to at least be maintained and possibly edged higher; and an update on the $2 billion share buyback, which could be approaching an end.
The firm sees EPS of $0.64, in-line with the consensus and at the high-end of co guidance; the firm sees the 2009 guidance range of $2.59-$2.64 to at least be maintained and possibly edged higher; and an update on the $2 billion share buyback, which could be approaching an end.
You May Also Be Interested In
- UBS Raises Price Target and EPS Estimate on LyondellBasell Industries (LYB); Use Dip As Buying Opportunity
- Canaccord Genuity Reiterates a 'Buy' on InterMune Inc. (ITMN); Reducing Estimates and PT
- Barclays Reiterates Cautious Stance on hhgregg (HGG); Lowering PT & Estimates
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Goldman Sachs Conviction Buy List, Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
